Ovalbumin으로 유발된 천식 동물모델에서 GGX의 효과

키워드

참고문헌 (58)

1. Anderson GP, "Endotyping asthma : new insights into key pathogenic mechanisms in a complex, heterogeneous disease", Lancet, 372(9643), pp.1107~1119 (2008)
2. Kuipers H, "The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma", Curr Opin Immunol, 16(6), pp.702~708 (2004)
3. Scanlon ST, "Type 2 innate lymphoid cells : new players in asthma and allergy", Curr Opin Immunol, 24(6), pp.707~712 (2012)
4. Gans MD, "Understanding the immunology of asthma : Pathophysiology, biomarkers, and treatments for asthma endotypes", Paediatr Respir Rev, 36, pp.118~127 (2020)
5. Bousquet J, "Asthma. From bronchoconstriction to airways inflammation and remodeling", Am J Respir Crit Care Med, 161(5), pp.1720~1745 (2000)
6. James A, "Airway remodeling in asthma", Curr Opin Pulm Med, 11(1), pp.1~6 (2005)
7. Kaminska M, "Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction", J Allergy Clin Immunol, 124(1), pp.45~51 (2009)
8. 이응구, "천식 치료의 원칙과 새로운 약제의 적절한 사용", 대한의사협회지, 65(1), pp.44~54 (2022), 대한의사협회[DOI]
9. Ahmet A, "Adrenal suppression : a practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy", Allergy Asthma Clin Immunol, 7(1), pp.13~ (2011)
10. Jacobson GA, "Long-Acting β2-Agonists in Asthma : Enantioselective Safety Studies are Needed", Drug Saf, 41(5), pp.441~449 (2018)
11. Rank MA, "Stepping down from inhaled corticosteroids with leukotriene inhibitors in asthma : a systematic review and meta-analysis", Allergy Asthma Proc, 36(3), pp.200~205 (2015)
12. Kang SW, "Therapeutic Potential of Chungsangboha-tang for the Treatment of Asthma : A Review of Preclinical and Clinical Studies", J Clin Med, 11(14), pp.4035~ (2022)
13. Lim CY, "Genome wide expression analysis of the effect of Socheongryong Tang in asthma model of mice", J Tradit Chin Med, 35(2), pp.168~174 (2015)
14. 김진주, "麥門冬湯과 定喘化痰降氣湯이 알레르기 천식 모델 흰쥐으 BALF內 면역세포 및 혈청 lgE에 미치는 영향", 대한한의학회지, 23(1), pp.37~49 (2002), 대한한의학회
15. 박청수, "천식의 한약치료에 관한 문헌고찰 - 국내 한의학 임상연구를 중심으로", 동의생리병리학회지, 32(6), pp.361~369 (2018), 한의병리학회[DOI]
16. Hwang DY, "Bang-yak-hap-pyeon", pp.240~ (1986), Namsandang
17. Herbology Editorial Committee of Korean Medicine schools, "Boncho-hak", pp.124~125 (1991), Younglimsa
18. Lyu YR, "Inhibitory effects of modified gamgil-tang in a particulate matter-induced lung injury mouse model", J Ethnopharmacol, 284, pp.114789~ (2022)
19. 김태현, "만성폐쇄성폐질환 동물모델에서 GGX의 폐손상 억제 효과", 대한한의학회지, 42(3), pp.56~71 (2021), 대한한의학회
20. Dey S, "Pathogenesis, clinical features of asthma COPD overlap, and therapeutic modalities", Am J Physiol Lung Cell Mol Physiol, 322(1), pp.L64~L83 (2022)[DOI]
21. Tanaka H, "The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma", Inflamm Res, 50(12), pp.616~624 (2001)
22. Lee MY, "Anti-inflammatory and anti-allergic effects of kefir in a mouse asthma model", Immunobiology, 212(8), pp.647~654 (2007)
23. Collaborators GCRD, "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015 : a systematic analysis for the Global Burden of Disease Study 2015", Lancet, 388(10053), pp.1545~1602 (2016)
24. The eighth Korea National Health and Nutrition Examination Survey (KNHANES VIII-1), "Korea Disease Control and Prevention Agency", orea Disease Control and Prevention Agency, ~ (2020)
25. Masoli M, "The global burden of asthma : executive summary of the GINA Dissemination Committee report", Allergy, 59(5), pp.469~478 (2004)
26. Lee EW, "Socioeconomic Burden of Disease Due to Asthma in South Korea", Asia Pac J Public Health, 32(4), pp.188~193 (2020)
27. Busse WW, "Asthma", N Engl J Med, 344(5), pp.350~362 (2002)
28. Burke W, "Family history as a predictor of asthma risk", Am J Prev Med, 24(2), pp.160~169 (2003)
29. Abreo A, "The impact of modifiable risk factor reduction on childhood asthma development", Clin Transl Med, 7(1), pp.15~ (2018)
30. Haahtela T, "A 10 year asthma programme in Finland : major change for the better", Thorax, 61(8), pp.663~670 (2006)
31. 김성수, "桔梗에 의한 알레르기 천식효과에 대한 연구", 대한본초학회지, 19(2), pp.61~70 (2004), 대한본초학회
32. 정진기, "난알부민 유도 알레르기 면역반응에 대한 길경(桔梗)에탄올추출물의 효능 연구", 대한본초학회지, 27(6), pp.123~129 (2012), 대한본초학회
33. 박치영, "桔梗藥鍼의 喘息抑制 및 免疫調節效果에 對한 實驗的 硏究", Journal of Pharmacopuncture, 9(3), pp.23~35 (2006), 대한약침학회
34. 조은희, "감초 추출물 투여가 Ovalbumin으로 유발된마우스 알레르기성 천식에 미치는 영향", 한방안이비인후피부과학회지, 27(3), pp.96~105 (2014), 대한한방안이비인후피부과학회
35. 한영주, "감초(Glycyrrhiza uralensis Fisch, GLU)가 천식모델 생쥐의 BALF내 면역세포 및 Cytokine에 미치는 효과", 대한한방내과학회지, 25(3), pp.408~417 (2004), 대한한방내과학회
36. 김정미, "감초 추출물이 RBL-2H3 비만세포에서 β-hexosaminidase 분비 및 Th2 cytokine mRNA 발현에 미치는 효과", 한국약용작물학회지, 18(4), pp.231~237 (2010), 한국약용작물학회
37. 정광진, "金銀花가 喘息유발 cytokine 분비와 호산구 chemotaxis에 미치는 영향", 대한한방내과학회지, 26(1), pp.1~15 (2005), 대한한방내과학회
38. Kang OH, "Luteolin isolated from the flowers of Lonicera japonica suppresses inflammatory mediator release by blocking NF-kappaB and MAPKs activation pathways in HMC-1 cells", Molecules, 15(1), pp.385~398 (2010)
39. 강석용, "난알부민으로 유도된 천식 마우스에서 상백피 추출물의 면역조절효능 연구", 대한본초학회지, 29(4), pp.1~8 (2014), 대한본초학회
40. 김정미, "상백피 물 추출물의 항산화 활성 및 항천식 효과", 한국식품영양과학회지, 39(9), pp.1263~1269 (2010), 한국식품영양과학회
41. Anderson GP, "Endotyping asthma : new insights into key pathogenic mechanisms in a complex, heterogeneous disease", Lancet, 372(9643), pp.1107~1119 (2008)
42. DeGrendele HC, "Requirement for CD44 in activated T cell extravasation into an inflammatory site", Science, 278(5338), pp.672~675 (1997)
43. Matucci A, "High proportion of inflammatory CD62L low eosinophils in blood and nasal polyps of severe asthma patients", Clin Exp Allergy (2022)[DOI]
44. Kang JS, "B cell-activating factor is a novel diagnosis parameter for asthma", Int Arch Allergy Immunol, 141(2), pp.181~188 (2006)
45. Tang S, "Effect of CCR3 gene on related inflammatory cells in respiratory allergic diseases", Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 35(1), pp.80~84 (2021)
46. Miki-Hosokawa T, "CD69 controls the pathogenesis of allergic airway inflammation", J Immunol, 183(12), pp.8203~8215 (2009)
47. Percopo CM, "SiglecF+Gr1hi eosinophils are a distinct subpopulation within the lungs of allergen-challenged mice", J Leukoc Biol, 101(1), pp.321~328 (2017)
48. Spoelstra FM, "Changes in CD11b and L-selectin expression on eosinophils are mediated by human lung fibroblasts in vitro", Am J Respir Crit Care Med, 158(3), pp.769~777 (1998)
49. Steinke JW, "Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists", Respir Res, 2(2), pp.66~70 (2001)
50. Konig K, "Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis", Allergy Asthma Clin Immunol, 11(1), pp.26~ (2015)
51. Pelaia C, "Interleukin-5in the Pathophysiology of Severe Asthma", Front Physiol, 10, pp.1514~ (2019)
52. Corren J, "Role of interleukin-13 in asthma", Curr Allergy Asthma Rep, 13(5), pp.415~420 (2013)
53. Kumar RK, "Interferon-gamma as a possible target in chronic asthma", Inflamm Allergy Drug Targets, 5(4), pp.253~256 (2006)
54. Lambrecht BN, "The Cytokines of Asthma", Immunity, 50(4), pp.975~991 (2019)[DOI]
55. Berin MC, "The Role of TARC in the Pathogenesis of Allergic Asthma", Drug News Perspect, 15(1), pp.10~16 (2002)
56. Rose CE Jr, "Significant involvement of CCL2(MCP-1)in inflammatory disorders of the lung", Microcirculation, 10(3-4), pp.273~288 (2003)
57. Nikolskii AA, "Role of STAT3 Transcription Factor in Pathogenesis of Bronchial Asthma", Biochemistry(Mosc), 86(11), pp.1489~1501 (2021)
58. Barnes PJ, "Role of GATA-3 in allergic diseases", Curr Mol Med, 8(5), pp.330~334 (2008)

관련 논문AI추천